Royal seal of approval for Wales-based resin manufacturer Purolite

Purolite, an Ecolab company and leading manufacturer of synthetic and agarose-based resins used in the bioprocessing industry, has been awarded the prestigious Queen’s Award for Enterprise in the International Trade category.

CD Formulation Enriches Its Supply of Active Pharmaceutical Ingredient Excipients

Continuing to be a trust-worthy CRO company for drug formulation and development, CD Formulation recently announces the enrichment of its active pharmaceutical ingredient excipient offerings. Now a number of API excipients are readily obtainable at CD Formulation, including Cetrorelix Acetate, Fondaparinux Sodium, Calcitriol, Vitamine D3, Tirofiban Hydrochloride, Eptifibatide, Ferric Ammonium Citrate, Calcipotriol API, Calcium Orotate, Meglumine, Obeticholic Acid, Potassium Magnesium Citrate and Magnesium Oxide.

Adsorptive Polymers Are Now Available at Alfa Chemistry for Applications in Water Treatment, Medicine, Health Care, and Machine Processing

Alfa Chemistry Launches Heat Stabilizers for PVC Industry

Biopharma PEG Develops PEG Derivatives for ADCs Development

Biopharma PEG leapts at the opportunity to develop various high purity PEG derivatives used as ADC linkers.

1upHealth Unveils Data Conversion App.

Good afternoon, all -- 1upHealth, an intelligent health data platform with over 10,000 clinical and payer endpoints, today unveiled SQL on FHIR to streamline access to and make FHIR healthcare data computable to help organizations discover analytical insights and create compelling visualizations. SQL on FHIR allows healthcare organizations to convert FHIR data into a form that is easily searchable for specifics such as a patient’s observations, vital signs, and smoking status. This new platform is the next phase of 1upHealth’s mission to solve healthcare’s biggest data challenges, including helping organizations convert legacy claims and clinical data into clean, uniform FHIR. If interested in learning more about SQL on FHIR, I am happy to connect you with FHIR expert Joe Gagnon, CEO of 1upHealth, and/or a health plan executive to discuss the following: • Why SQL on FHIR fills the market gap for data conversion and will further aid healthcare organizations to perform at their highest levels • Strategies for organizations to enable FHIR analytics to reduce cost and improve operating models, quality metrics, and outcomes • The urgency to convert FHIR into searchable metrics with interoperability regulations looming and how this will help organizations further track and improve population health and SDoH The full release is included above. Please let me know if you have any questions or requests. Thanks! Anisa

Samsung Biologics Reports First Quarter 2022 Financial Results

CD ComputaBio Unveils Protein Structure Modeling Service for Drug Development

Untargeted Lipidomics Now Available with Creative Proteomics’s New Cutting-Edge Lipidomics Platform

Pronalyse Unveils Gene Therapy Products Characterization Service to Safely Accelerate Drug Development

Creative Proteomics Metabolomics Expands Service Offering with the Launch of Plant Untargeted Metabolomics Service

Global Biologics CDMO Market is set to witness a CAGR of 15% to reach $35 billion by 2025, driven by the growing biopharmaceutical end market

Rapidly expanding pipelines of cell & gene therapies and new vaccines and significant VC fundings are driving the growth of the Biologics CDMO market.

Biofourmis Receives Significant Growth Investment from General Atlantic to Propel Company to Unicorn Status

With this investment, Biofourmis plans to scale up its virtual care offerings. This includes delivering personalized and predictive in-home care to a growing number of acutely ill patients and expanding its recently announced virtual specialty care services, Biofourmis Care, to those patients with complex chronic conditions. In parallel, Biofourmis plans to fund clinical trials to advance the development of digital therapies that work in conjunction with high-value drugs to improve efficacy, while forming strategic partnerships with companies in the digital health and virtual-first care ecosystems.

Onyx Scientific opens second site and expands small molecule CMC services

WCG Selected as the Institutional Review Board of Record for The Michael J. Fox Foundation’s Parkinson’s Progression Markers Initiative

PPMI is designed to identify biological markers and clinical changes associated with Parkinson’s disease risk, onset, and progression.

CTL Amedica Corp. Awarded U.S. Patent for KLIMT™ Expandable Lumbar Interbody Fusion Cage Design

The US Patent and Trademark Office has awarded CTL Amedica Corporation US PAT 11, 291.559, an official patent for the KLIMT™ Expandable Lumbar Interbody Fusion Cage design. The KLIMT™ features proprietary, 3D-printed, expandable technology.

New Genedata Screener 19.0 Further Accelerates Biotherapeutics R&D

The latest version of Genedata Screener features smart workflow automation and fit-for-purpose, big data visualizations that enable fast, functional characterization of tens of thousands of candidate molecules.

MicrobioSeq Introduces Fungal Whole-Genome De Novo Sequencing Platform to Facilitate Microbial Research

CD Genomics Releases Human Mitochondrial DNA Sequencing for Disease Research and Biodiversity Assessment

“International Conference on Veterinary Science” (VET 2022)